# US 2010/0168392 A1 · Expression of full length igg and secretion into the culture medium of prokaryotic cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168392 A1
- Document ID: US20100168392A1
- Status: Published application
- Kind: A1
- Application number: 12/672,859
- Filed: 2007-08-10
- Published: 2010-07-01
- Earliest claimed: 2007-08-10
- Assignees: Wacker Chemie AG
- Inventors: Ralf Ostendorp; Andreas Popp; Martina Fischer
- Web page: https://patentgrep.com/patent/US20100168392A1

## CPC

- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 2317/10: characterized by their source of isolation or production
- C07K 2319/035: containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method for the production of an immunoglobulin or a functional fragment thereof in a prokaryotic host cell comprises transforming the host cell with (a) a first nucleic acid molecule comprising a nucleic acid sequence encoding a VL and a CL region and (b) a second nucleic acid molecule comprising a nucleic acid sequence encoding a VH, a CH1, a CH2 and at least a portion of a CH3 region, The host cell is within culture medium. The host cell is cultured under conditions so as to allow the host cell (a) to express (1) the VL and a CL region and (2) the VH, the CH1, the CH2 and the portion of the CH3 region, and (b) to secrete (a)(1) and (a)(2) to the periplasm of the host cell and thereafter to the culture medium of the host cell. Characteristically, (a)(1) and (a)(2) interact to form the immunoglobulin or functional fragment thereof.

## Claims

### Claim 1

A method for the production of an immunoglobulin or a functional fragment thereof in a prokaryotic host cell, said method comprising:
a. transforming said host cell with (a) a first nucleic acid molecule comprising a nucleic acid sequence encoding a VL and a CL region and
(b) a second nucleic acid molecule comprising a nucleic acid sequence encoding a VH, a CH1, a CH2 and at least a portion of a CH3 region, wherein said host cell is within culture medium;
b. culturing said host cell under conditions so as to allow said host cell (a) to express (1) said VL and a CL region and (2) said VH, said CH1, said CH2 and said portion of said CH3 region, and (b) to secrete (a)(1) and (a)(2) to the periplasm of said host cell and thereafter to the culture medium of said host cell, wherein (a)(1) and (a)(2) interact to form said immunoglobulin or functional fragment thereof.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said heavy chain comprises a VH, a CH1, a CH2 and a full-length CH3 region.

### Claim 3 (depends on 1)

The method according to claim 1, wherein said immunoglobulin is a full-length immunoglobulin.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising the step of recovering said immunoglobulin or said functional fragment thereof from the culture medium.

### Claim 5 (depends on 1)

The method according to claim 1, wherein said immunoglobulin is an IgG.

### Claim 6 (depends on 5)

The method according to claim 5, wherein said IgG is IgG1.

### Claim 7 (depends on 1)

The method according to claim 1, wherein one or more of said first and said second nucleic acid molecules further comprises a nucleic acid sequence encoding for a signal sequence.

### Claim 8 (depends on 7)

The method according to claim 7, wherein each of said signal sequences is a prokaryotic signal sequences.

### Claim 9 (depends on 8)

The method according to claim 8, wherein one or more of said prokaryotic signal sequences is derived from Escherichia coli.

### Claim 10 (depends on 9)

The method according to claim 9, wherein said prokaryotic signal sequence is selected from the group consisting of the signal sequences of MalE, LamB, PelB, LivK, TorT, TolB, DsbA, Pac, TorA, PhoA and OmpA.

### Claim 11 (depends on 7)

The method according to claim 7, wherein either or both of said signal sequence is N-terminal with respect to the heavy chain and the light chain.

### Claim 12 (depends on 4)

The method according to claim 4, further comprising the step of purifying said immunoglobulin or said functional fragment thereof.

### Claim 13 (depends on 1)

The method according to claim 1, wherein said first and second nucleic acid molecules are operably linked to the same promoter.

### Claim 14 (depends on 1)

The method according to claim 1, wherein said first and second nucleic acid molecules are not operably linked to the same promoter.

### Claim 15 (depends on 1)

The method according to claim 1, wherein said first and second nucleic acid molecules are within the same vector.

### Claim 16 (depends on 1)

An immunoglobulin or a functional fragment thereof produced according to claim 1.

### Claim 17 (depends on 1)

An immunoglobulin or a functional fragment thereof produced according to claim 1, wherein said immunoglobulin or said functional fragment thereof is aglycosylated.

### Claim 18 (depends on 1)

The method of claim 1 wherein said immunoglobulin or a functional fragment thereof, wherein said immunoglobulin or said functional fragment thereof is secreted into the culture medium.

### Claim 19 (depends on 1)

The method of claim 1, wherein said immunoglobulin or functional fragment thereof comprises a VL and a CL region and a VH, a CH1, a CH2 and at least a portion of a CH3 region.

### Claim 20 (depends on 18)

The method of claim 18, wherein said prokaryotic host cell carries a mutation in at least one protein of the outer membrane.

### Claim 21 (depends on 18)

The method of claim 18, wherein said prokaryotic host cell is Escherichia coli.

### Claim 22 (depends on 21)

The method of claim 21, wherein said Escherichia coli carries a mutation in the gene minA and/or minB.

### Claim 23 (depends on 20)

The method of claim 20, wherein said Escherichia coli is Escherichia coli strain WCM104 or Escherichia coli strain WCM105.
